Watch this overview of the drug discovery and development process to learn the stages and challenges in every step. Join experts from Pfizer, Vertex and Bristol-Myers Squibb to discuss pre-clinical ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

For example, instead of initiating the drug development process by focusing on a promising target, 'tumour strategy teams' at pharmaceutical and biotechnology companies, working with experts ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

The pharmaceutical industry has long been reliant on rigorous research and development processes to bring life-saving drugs to market ... delays in the development process to the tune of months ...

These venues for discussion and debate are essential for allowing the scientific process to unfold ... you can make a difference. Development of new drugs is inherently complex and costly, with ...

Fortunately, cutting-edge technologies such as AI, blockchain, and big data have the potential to eliminate costly inefficiencies in the drug discovery and development process. The high risk ...

Join Principal Consultant Michael W. Dong of MWD Consulting as he shares his unique perspective on current trends and job opportunities in pharma, the fundamentals of assessing drug quality, and the ...

Drug discovery and development is an extremely lengthy and expensive process; yet drug safety, a fundamental part of this process, continues to be a major unaddressed problem. The problem of ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

Qualification program creates a pathway to evaluate Clinical Outcome Assessments (COAs) that capture a specific concept of interest (COI) in a specified Context of Use (COU). If successfully qualified ...

"C-Path was built on the vision that no single entity can solve the challenges of the drug development process alone," said former C-Path CEO Dr. Woosley. "Over the last 20 years, C-Path has ...